Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Psoriasis and Vascular Risk: an Update.

Katsiki N, Anagnostis P, Athyros VG, Karagiannis A, Mikhailidis DP.

Curr Pharm Des. 2014 Apr 16. [Epub ahead of print]

PMID:
24745923
[PubMed - as supplied by publisher]
2.

Metabolic syndrome and non-cardiac vascular diseases: an update from human studies.

Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP.

Curr Pharm Des. 2014;20(31):4944-52.

PMID:
24320038
[PubMed - in process]
3.

Metabolic comorbidities and psoriasis.

Gisondi P, Ferrazzi A, Girolomoni G.

Acta Dermatovenerol Croat. 2010;18(4):297-304. Review.

PMID:
21251450
[PubMed - indexed for MEDLINE]
4.

Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.

Tobin AM, Veale DJ, Fitzgerald O, Rogers S, Collins P, O'Shea D, Kirby B.

J Rheumatol. 2010 Jul;37(7):1386-94. doi: 10.3899/jrheum.090822. Epub 2010 May 15. Review.

PMID:
20472927
[PubMed - indexed for MEDLINE]
5.

Cardiometabolic comorbidities and the approach to patients with psoriasis.

Gisondi P, Girolomoni G.

Actas Dermosifiliogr. 2009 Dec;100 Suppl 2:14-21.

PMID:
20096157
[PubMed - indexed for MEDLINE]
6.

Metabolic disorders in patients with psoriasis and psoriatic arthritis.

Mallbris L, Ritchlin CT, Ståhle M.

Curr Rheumatol Rep. 2006 Oct;8(5):355-63. Review.

PMID:
16973109
[PubMed - indexed for MEDLINE]
7.

Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.

Gisondi P, Girolomoni G.

Semin Thromb Hemost. 2009 Apr;35(3):313-24. doi: 10.1055/s-0029-1222610. Epub 2009 May 18. Review.

PMID:
19452407
[PubMed - indexed for MEDLINE]
8.

The concept of psoriasis as a systemic inflammation: implications for disease management.

Reich K.

J Eur Acad Dermatol Venereol. 2012 Mar;26 Suppl 2:3-11. doi: 10.1111/j.1468-3083.2011.04410.x. Review.

PMID:
22356630
[PubMed - indexed for MEDLINE]
9.

Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.

Davidovici BB, Sattar N, Prinz J, Puig L, Emery P, Barker JN, van de Kerkhof P, Ståhle M, Nestle FO, Girolomoni G, Krueger JG.

J Invest Dermatol. 2010 Jul;130(7):1785-96. doi: 10.1038/jid.2010.103. Epub 2010 May 6. Review. Erratum in: J Invest Dermatol. 2010 Oct;130(10):2517. Jörg, Prinz C [corrected to Prinz, Jörg C].

PMID:
20445552
[PubMed - indexed for MEDLINE]
Free Article
10.

Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community.

Menter A, Griffiths CE, Tebbey PW, Horn EJ, Sterry W; International Psoriasis Council.

J Eur Acad Dermatol Venereol. 2010 Dec;24(12):1371-7. doi: 10.1111/j.1468-3083.2010.03656.x. Review.

PMID:
20384692
[PubMed - indexed for MEDLINE]
11.

The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.

Diamant M, Tushuizen ME.

Curr Diab Rep. 2006 Aug;6(4):279-86. Review. Erratum in: Curr Diab Rep. 2006 Dec;6(6):iii.

PMID:
16879779
[PubMed - indexed for MEDLINE]
13.

Psoriasis: comorbidities and associations.

Farley E, Menter A.

G Ital Dermatol Venereol. 2011 Feb;146(1):9-15. Review.

PMID:
21317853
[PubMed - indexed for MEDLINE]
14.

Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.

Boehncke WH, Boehncke S.

G Ital Dermatol Venereol. 2008 Oct;143(5):307-13. Review.

PMID:
18833072
[PubMed - indexed for MEDLINE]
15.

The role of statins in the treatment of type 2 diabetes mellitus: an update.

Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP.

Curr Pharm Des. 2014;20(22):3665-74.

PMID:
24040875
[PubMed - in process]
16.

Psoriasis: a skin disease associated with increased cardiovascular risk.

González-Gay MA, González-Vela C, González-Juanatey C.

Actas Dermosifiliogr. 2012 Sep;103(7):595-8. Epub 2012 Mar 31. Review. English, Spanish.

PMID:
22465257
[PubMed - indexed for MEDLINE]
17.

Comorbidities in psoriasis patients.

Kim N, Thrash B, Menter A.

Semin Cutan Med Surg. 2010 Mar;29(1):10-5. doi: 10.1016/j.sder.2010.01.002. Review.

PMID:
20430302
[PubMed - indexed for MEDLINE]
18.

[Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].

Daudén E, Castañeda S, Suárez C, García-Campayo J, Blasco AJ, Aguilar MD, Ferrándiz C, Puig L, Sánchez-Carazo JL; Grupo de Trabajo en Comorbilidades asociadas a la Psoriasis.

Actas Dermosifiliogr. 2012 Jan;103 Suppl 1:1-64. doi: 10.1016/S0001-7310(12)70001-7. Spanish.

PMID:
22364603
[PubMed - indexed for MEDLINE]
19.

Comorbidities in patients with psoriasis.

Gottlieb AB, Dann F.

Am J Med. 2009 Dec;122(12):1150.e1-9. doi: 10.1016/j.amjmed.2009.06.021. Review.

PMID:
19958894
[PubMed - indexed for MEDLINE]
20.

Metabolic syndrome in patients with psoriatic disease.

Gelfand JM, Yeung H.

J Rheumatol Suppl. 2012 Jul;89:24-8. doi: 10.3899/jrheum.120237.

PMID:
22751586
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk